EW

Edwards Lifesciences Corp
NYSE
85.22
+0.35
+0.41%
After Hours: 85.22 0 0.00% 16:02 03/01 EST
OPEN
84.40
PREV CLOSE
84.87
HIGH
85.74
LOW
83.61
VOLUME
3.30M
TURNOVER
0
52 WEEK HIGH
94.87
52 WEEK LOW
60.57
MARKET CAP
51.24B
P/E (TTM)
37.03
1D
5D
1M
3M
1Y
5Y
HOLX or EW: Which Is the Better Value Stock Right Now?
NASDAQ · 5d ago
Looking Into Edwards Lifesciences's Recent Short Interest
Edwards Lifesciences's short percent of float has fallen 8.29% since its last report. The company has 9.96 million shares sold short, which is 1.66% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 5d ago
Validea Detailed Fundamental Analysis - EW
NASDAQ · 6d ago
Edwards Lifesciences (EW) Gets a Buy from Wells Fargo
TipRanks · 6d ago
Weekly Report: what happened at EW last week (0219-0223)?
Weekly Report · 6d ago
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Edwards Lifesciences Corporation will participate in the TD Cowen Healthcare Conference on March 5, 2024. Bernard Zovighian and Scott Ullem are scheduled to present at 10:30 a.m. ET. A live webcast of the presentation will be available on the company's investor relations website.
Barchart · 02/23 06:05
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Edwards Lifesciences has outperformed the market over the past 15 years by 7.87%. EW has an average annual return of 21.54%. If an investor bought $1000 of EW stock 15 years ago, it would be worth $17,914.03 today.
Benzinga · 02/22 17:00
If You Invested $1000 in Edwards Lifesciences a Decade Ago, This is How Much It'd Be Worth Now
NASDAQ · 02/22 13:30
More
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. It sells products that are used to treat advanced cardiovascular disease in all regions.

Webull offers Edwards Lifesciences Corp stock information, including NYSE: EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.